Home
Storia in 1 fonti
China closing in but US leads in biotech quality and commercial reach: survey
The Cure survey said China leads in clinical development and supply chain, and rated US funding cuts a bigger threat than China competition.
Raccontata da
scmp.com
Timeline cronologica
- ·
China closing in but US leads in biotech quality and commercial reach: survey
The Cure survey said China leads in clinical development and supply chain, and rated US funding cuts a bigger threat than China competition.
- ·
China’s biotech boom: record 5,215 clinical drug trials reported in 2025
Cancer treatments remain the top research focus as Beijing’s drive to make biotech a strategic industry draws attention in Washington.